ZURICH, Nov. 6, 2025 /PRNewswire/ -- NewcelX Ltd. (NASDAQ: NCEL) ("NewcelX" or the "Company"), a biotechnology company advancing transformative therapies for...
Redefining Scalability, Automation, and Clinical Yield in Genomic Interpretation BOZEMAN, Mont., Nov. 6, 2025 /PRNewswire/ -- Golden Helix, Inc. announced the...
Sustained acoustic medicine from ZetrOZ Systems supports recovery when players face intense physical demands, such as an 18-inning game. TRUMBULL,...
An evidence-based look at a modern therapy advancing wellness and regenerative medicine WEST PALM BEACH, FLORIDA / ACCESS Newswire /...
MESA, ARIZONA / ACCESS Newswire / November 6, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE), led by CEO Marshall...
Toronto, Ontario--(Newsfile Corp. - November 6, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an...
One dose elicits robust and long-lasting immune responses in healthy adults in the U.S. and LiberiaKey takeaways:IAVI's Lassa vaccine candidate...
One dose elicits robust and long-lasting immune responses in healthy adults in the U.S. and LiberiaKey takeaways:IAVI's Lassa vaccine candidate...
Results of ongoing investigator-initiated proof-of-concept trial of crofelemer in United Arab Emirates (UAE) demonstrate disease progression modification and reduction of...
Results of ongoing investigator-initiated proof-of-concept trial of crofelemer in United Arab Emirates (UAE) demonstrate disease progression modification and reduction of...
ESTERO, FL / ACCESS Newswire / November 6, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer...
ESTERO, FL / ACCESS Newswire / November 6, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer...
Integration boosts Grid AI's deployment capacity as AI data-center power demand approaches 50 GW, growing by over 165% through 2030i...
Integration boosts Grid AI's deployment capacity as AI data-center power demand approaches 50 GW, growing by over 165% through 2030i...
VSee explores collaboration with Philippine Tuberculosis Society and former VP Leni Robredo to expand digital health innovation for Naga City...
VSee explores collaboration with Philippine Tuberculosis Society and former VP Leni Robredo to expand digital health innovation for Naga City...
89% of evaluable mipletamig patients achieve remission in combination therapy for frontline AML across two trialsIntroduces first trispecific molecules, APVO451...
89% of evaluable mipletamig patients achieve remission in combination therapy for frontline AML across two trialsIntroduces first trispecific molecules, APVO451...
Facial rejuvenation for men is evolving toward subtle refinement and structural enhancement, according to specialists at Becker Plastic Surgery in...
Facial rejuvenation for men is evolving toward subtle refinement and structural enhancement, according to specialists at Becker Plastic Surgery in...